redness and itching near injection site; redness and itching near injection site; swollen and hard; arm would be tender to touch; feel like a burning sensation; fatigue; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 73 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 25Feb2021 14:30 (Lot number: EM9809) at the age of 73 years as single dose for covid-19 immunisation. Relevant medical history included: "well controlled seizure disorder" (unspecified if ongoing), notes: well controlled seizure disorder and well controlled HTN, IBS, diverticulosis; "well controlled HTN" (unspecified if ongoing), notes: well controlled seizure disorder and well controlled HTN, IBS, diverticulosis; "IBS" (unspecified if ongoing), notes: well controlled seizure disorder and well controlled HTN, IBS, diverticulosis; "diverticulosis" (unspecified if ongoing), notes: well controlled seizure disorder and well controlled HTN, IBS, diverticulosis; "known allergies sulfa" (unspecified if ongoing); "had a skin reaction of redness and swelling after flu shot", start date: 29Sep2020 (unspecified if ongoing), notes: had a local skin reaction of redness and swelling after flu shot in same (left) arm on 29Sep2020; "had a skin reaction of redness and swelling after flu shot", start date: 29Sep2020 (unspecified if ongoing), notes: had a local skin reaction of redness and swelling after flu shot in same (left) arm on 29Sep2020. Concomitant medication(s) included: UNITHROID; PHENYTOIN; METAMUCIL CITRON; LORAZEPAM. Past drug history included: Erythromycin, reaction(s): "known allergies: erythromycin"; Epinephrine, reaction(s): "sensitive to epinephrine". Vaccination history included: Bnt162b2 ({product=COVID 19, brand=Pfizer,, lot number=EL9265,, lot unknown=False,, administration date=04Feb2021,, administration time=12:30 PM,, vaccine location=Left arm,, dose number=1}), administration date: 04Feb2021, when the patient was 73 years old, for COVID-19 immunisation, reaction(s): "sore injection site". The following information was reported: INJECTION SITE ERYTHEMA (non-serious), INJECTION SITE PRURITUS (non-serious) all with onset 26Feb2021 02:00, outcome "not recovered" and all described as "redness and itching near injection site"; INJECTION SITE SWELLING (non-serious) with onset 26Feb2021 02:00, outcome "not recovered", described as "swollen and hard"; INJECTION SITE PAIN (non-serious) with onset 26Feb2021 02:00, outcome "not recovered", described as "arm would be tender to touch"; BURNING SENSATION (non-serious) with onset 26Feb2021 02:00, outcome "not recovered", described as "feel like a burning sensation"; FATIGUE (non-serious) with onset 26Feb2021 02:00, outcome "not recovered", described as "fatigue". The events "redness and itching near injection site", "redness and itching near injection site", "swollen and hard", "arm would be tender to touch", "feel like a burning sensation" and "fatigue" were evaluated at the physician office visit. Therapeutic measures were taken as a result of injection site erythema, injection site pruritus, injection site swelling, injection site pain, burning sensation, fatigue.  No follow-up attempts are possible. No further information is expected.